Abstract:Objective:To Compare the difference between only primary percutaneous coronary intervention and thrombus-aspiration and/or platelet glycoprotein Ⅱb/Ⅲa receptor antagonists(GPⅡb/Ⅲa) in the patients with ST-segment elevation myocardial infarction(STEMI) during the primary percutaneous coronary intervention(PCI),we try to explore the best strategies to reduce thrombus burden and improve myocardial reperfusion.Method:We reviewed 206 STEMI patients who had done with primary PCI.The patients were arranged into 3 groups,including only primary percutaneous coronary intervention group,thrombus-aspiration or GPⅡb/Ⅲa receptor antagonists group and thrombus-aspiration plus GPⅡb/Ⅲa receptor antagonists group.We compare the different targets among the three groups,including rate of no-reflow or slow-reflow,post-procedure Thrombolysis In Myocardial Infarction(TIMI) frame counts,50% ST-segment elevation resolution(STR),the figures of Left ventricular ejection fraction(LVEF) and Left ventricular diastole diameter(LVDd) by UCG,the rate of major haemorrhage,mortality in hospital.Result:Comparing with the only primary PCI group,thrombus-aspiration plus GP Ⅱb/Ⅲa receptor antagonists group have no statistics significant difference in risk of no-reflow or slow-reflow,TIMI frame counts,50% STR(P>0.05),but have more TIMI 0-1 blood rate flow pre-procedure(P<0.05).The figures of LVEF and LVDD by UCG and mortality in hospital were no difference among three groups(P>0.05).The rate of major haemorrhage was no difference among three groups(P>0.05).Conclusion:The combine of thrombus-aspiration and Ⅱb/Ⅲa antagonists can reduce thrombus burden,prevent the rate of no-reflow andimprove myocardial microvascular reperfusion in patients with STEMI during direct PCI.

To explore clinical use of thrombus aspiration and platelet glycoprotein Ⅱb/Ⅲa receptor antagonists during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients